Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of a Metallic Cannula Versus A Standard Needle for Soft Tissue Augmentation of the Nasolabial Folds

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects agreeing to take part of the study, after being fully informed of the purpose and the nature of the investigation and after having signed the informed consent form~* Female subjects aged from 18 to 60~* Fitzpatrick phototype I to VI~* Presence of bilateral folds graded from 2 to 3 according to the Modified~* Fitzpatrick Wrinkle Scale~* Subjects that have never performed any treatment of nasolabial folds~* Female subjects of childbearing age that present a negative urine pregnancy test and are using an effective contraceptive method~* Subjects who will be available throughout the duration of the study~* Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.~Exclusion Criteria:~* Use of systemic corticosteroids~* History of herpes in lip~* Inflammation or active infection in the area to be injected~* Any surgical treatment or cosmetic procedure in the area to be injected that interfere in study's outcomes~* Coagulation disorders or use of anticoagulants~* Previous hypersensitivity responses to Hyaluronic acid.~* Pregnant or women in breastfeeding, or women planning to become pregnant

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Metallic cannula (Type: EXPERIMENTAL): Nasolabial Fold with metallic cannula and hyaluronic acid injected. hyaluronic acid with metallic cannula or standard needle. Hyaluronic acid injected with the new tool
- Standard needle (Type: ACTIVE_COMPARATOR): Nasolabial Fold with standard needle and hyaluronic acid injected. hyaluronic acid with metallic cannula or standard needle.

Based on this trial design, predict the completion outcome and termination type (if applicable).